A C Newby

Summary

Affiliation: University of Bristol
Country: UK

Publications

  1. ncbi Targets for gene therapy of vein grafts
    A C Newby
    Bristol Heart Institute, University of Bristol, United Kingdom
    Curr Opin Cardiol 14:489-94. 1999
  2. ncbi Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates
    Andrew C Newby
    University of Bristol, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    Cardiovasc Res 69:614-24. 2006
  3. ncbi Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
    A C Newby
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, UK
    Cardiovasc Res 41:345-60. 1999
  4. ncbi Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
    Andrew C Newby
    Bristol Heart Institute, University of Bristol, United Kingdom
    Physiol Rev 85:1-31. 2005
  5. ncbi Do metalloproteinases destabilize vulnerable atherosclerotic plaques?
    Andrew C Newby
    Bristol Heart Institute, Royal Infirmary, University of Bristol, Bristol BS2 8HW, UK
    Curr Opin Lipidol 17:556-61. 2006
  6. ncbi Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability
    Andrew C Newby
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    Arterioscler Thromb Vasc Biol 28:2108-14. 2008
  7. ncbi Metalloproteinases and vulnerable atherosclerotic plaques
    Andrew C Newby
    University of Bristol, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW
    Trends Cardiovasc Med 17:253-8. 2007
  8. ncbi Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes
    Andrew C Newby
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    Thromb Haemost 101:1006-11. 2009
  9. ncbi Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis
    A H Baker
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Marlborough Road, Bristol BS2 8HW, United Kingdom
    J Clin Invest 101:1478-87. 1998
  10. ncbi Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3
    S J George
    Bristol Heart Institute, University of Bristol, Bristol, UK
    Circulation 101:296-304. 2000

Collaborators

Detail Information

Publications65

  1. ncbi Targets for gene therapy of vein grafts
    A C Newby
    Bristol Heart Institute, University of Bristol, United Kingdom
    Curr Opin Cardiol 14:489-94. 1999
    ..Nitric oxide synthase, prostacyclin synthase, and tissue inhibitors of metalloproteinases have been used to reduce neointima formation, and vein graft atheroma remains a challenge for the future...
  2. ncbi Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates
    Andrew C Newby
    University of Bristol, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    Cardiovasc Res 69:614-24. 2006
    ..We conclude that MMPs influence VSMC behaviour by cleaving both matrix and non-matrix substrates...
  3. ncbi Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
    A C Newby
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, UK
    Cardiovasc Res 41:345-60. 1999
    ..Impaired cap formation caused by smooth muscle senescence, mummification and propensity to apoptosis may be as important as increased cap destruction in promoting plaque rupture...
  4. ncbi Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
    Andrew C Newby
    Bristol Heart Institute, University of Bristol, United Kingdom
    Physiol Rev 85:1-31. 2005
    ..Inhibiting the activity of specific MMPs or preventing their upregulation could ameliorate intimal thickening and prevent myocardial infarction...
  5. ncbi Do metalloproteinases destabilize vulnerable atherosclerotic plaques?
    Andrew C Newby
    Bristol Heart Institute, Royal Infirmary, University of Bristol, Bristol BS2 8HW, UK
    Curr Opin Lipidol 17:556-61. 2006
    ..Evidence is reviewed from genetically modified mice and human biomarker and genetic studies that sheds light on this dual role of metalloproteinases...
  6. ncbi Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability
    Andrew C Newby
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    Arterioscler Thromb Vasc Biol 28:2108-14. 2008
    ..Moreover, recent evidence suggests that different macrophage phenotypes express characteristically different spectra of MMPs and their inhibitors. New therapies may result from targeting matrix MMP overproduction...
  7. ncbi Metalloproteinases and vulnerable atherosclerotic plaques
    Andrew C Newby
    University of Bristol, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW
    Trends Cardiovasc Med 17:253-8. 2007
    ..Given the dual effects of MMPs, therapies should selectively target harmful MMPs or the processes that cause MMP activity to rise to destructive levels...
  8. ncbi Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes
    Andrew C Newby
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    Thromb Haemost 101:1006-11. 2009
    ..These phenotypes could play differing roles in cap, core and aneurysm formation...
  9. ncbi Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis
    A H Baker
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Marlborough Road, Bristol BS2 8HW, United Kingdom
    J Clin Invest 101:1478-87. 1998
    ..These findings have important implications for the physiological roles of TIMPs and their use in gene therapy...
  10. ncbi Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3
    S J George
    Bristol Heart Institute, University of Bristol, Bristol, UK
    Circulation 101:296-304. 2000
    ..Here, we overexpressed TIMP-3 at the luminal surface of human saphenous veins before organ culture and in pig saphenous veins before interposition grafting into carotid arteries in vivo to assess neointima formation...
  11. ncbi Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells
    M Bond
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, BS2 8HW, Bristol, UK
    Cardiovasc Res 50:556-65. 2001
    ..Moreover, an NF-kappaB binding site is present in the promoter of the MMP-9 gene and an NF-kappaB-like element in the promoter of the MMP-1 gene...
  12. ncbi Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts
    K M Southgate
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK
    Arterioscler Thromb Vasc Biol 19:1640-9. 1999
    ..MMPs therefore constitute new therapeutic targets for reducing late vein graft failure...
  13. ncbi Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity
    M Bond
    Bristol Heart Institute, Level 7, Bristol Royal Infirmary, University of Bristol, Bristol BS2 8HW, United Kingdom
    J Biol Chem 275:41358-63. 2000
    ....
  14. ncbi Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity
    A B Zaltsman
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK
    Arterioscler Thromb Vasc Biol 19:1700-7. 1999
    ..In summary, atherosclerosis increases TIMP expression, which counterbalances, in part, increased MMP activity...
  15. ncbi Molecular mechanisms in intimal hyperplasia
    A C Newby
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    J Pathol 190:300-9. 2000
    ..It emphasizes the key roles played by growth factors and extracellular matrix-degrading metalloproteinases, which act in concert to remodel the extracellular matrix and permit cell migration and proliferation...
  16. ncbi An overview of the vascular response to injury: a tribute to the late Russell Ross
    A C Newby
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK
    Toxicol Lett 112:519-29. 2000
    ..It will also consider the implications for the consequences and early detection of vascular drug toxicity...
  17. ncbi Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture
    M F Crook
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK
    Atherosclerosis 150:33-41. 2000
    ....
  18. ncbi Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619
    S Muzaffar
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK
    Prostaglandins Leukot Essent Fatty Acids 78:247-55. 2008
    ..The effect of the NO donor, NONOate and iloprost on O(2)(-) formation, p47(phox) and Rac(1) activation in human vascular smooth muscle cells (hVSMCs) was investigated...
  19. ncbi In vitro and in vivo analysis of expression cassettes designed for vascular gene transfer
    S J White
    Bristol Heart Institute, University of Bristol, Bristol, UK
    Gene Ther 15:340-6. 2008
    ..In conclusion, elements from the LOX-1 promoter and Tie2 enhancer together with an intron can be used to improve vectors for vascular gene transfer...
  20. ncbi Cloning of a mouse cytosolic 5'-nucleotidase-I identifies a new gene related to human autoimmune infertility-related protein
    G B Sala-Newby
    Bristol Heart Institute, Bristol Royal Infirmary, University of Bristol, BS2 8HW, Bristol, UK
    Biochim Biophys Acta 1521:12-8. 2001
    ..Our data imply the existence of at least two genes for cN-I, cN-I(A), previously cloned from pigeon and human, and cN-I(B) that we report here from mouse and partially from human...
  21. ncbi Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
    A H Baker
    University of Bristol, Division of Surgery, Bristol Royal Infirmary, UK
    Br J Cancer 79:1347-55. 1999
    ..These results show that TIMP-3 inhibits invasion in vitro and promotes apoptosis in cancer cell type of differing origin. This clearly identifies the potential of TIMP-3 for gene therapy of multiple cancer types...
  22. ncbi Macro-porosity is necessary for the reduction of neointimal and medial thickening by external stenting of porcine saphenous vein bypass grafts
    S J George
    Division of Cardiothoracic Surgery, Bristol Heart Institute, Bristol Royal Infirmary, University of Bristol, BS2 8HW, Bristol, UK
    Atherosclerosis 155:329-36. 2001
    ..This study establishes that macro-porosity is one essential feature required to reduce PDGF expression cell proliferation and neointima formation...
  23. ncbi Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate
    S Muzaffar
    Bristol Heart Institute, University of Bristol, Bristol, UK
    Br J Pharmacol 155:847-56. 2008
    ..To determine whether there is an association between vascular NADPH oxidase (NOX), superoxide, the small GTPase Rac(1) and PDE type 5 (PDE5) in human vascular smooth muscle cell (hVSMCs)...
  24. ncbi Distinct roles for recombinant cytosolic 5'-nucleotidase-I and -II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines
    G B Sala-Newby
    University of Bristol, Bristol Heart Institute, Bristol BS2 8HW, United Kingdom
    J Biol Chem 275:11666-71. 2000
    ..Our results imply distinct roles for cN-I and cN-II. Under the conditions tested in these cells, only cN-I plays a significant role in AMP breakdown to adenosine, whereas only cN-II breaks down IMP to inosine and GMP to guanosine...
  25. ncbi Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane
    M A Majid
    Academic Unit of Ophthalmology, University of Bristol, Bristol Eye Hospital, Bristol, UK
    Br J Ophthalmol 90:1310-5. 2006
    ....
  26. ncbi Identification of the prosurvival activity of nerve growth factor on cardiac myocytes
    A Caporali
    The Bristol Heart Institute, University of Bristol, Bristol, UK
    Cell Death Differ 15:299-311. 2008
    ..DN.Akt) or an Akt-resistant Foxo-3a (Ad.AAA-Foxo-3a). These results newly demonstrate the cardiac prosurvival action of NGF and provide mechanistic information on the signaling pathway, which encompasses trkA, PI3K-Akt, and Foxo...
  27. ncbi Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages
    Zhaoxia Luan
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    Arterioscler Thromb Vasc Biol 23:769-75. 2003
    ..Statins did not affect MMP mRNA levels. CONCLUSIONS: Statins inhibit secretion of a several MMPs from both SMCs and macrophages, which could therefore contribute to their plaque-stabilizing effects...
  28. ncbi Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation
    Yih-Jer Wu
    Bristol Heart Institute, University of Bristol, United Kingdom
    Circ Res 98:1141-50. 2006
    ..These data demonstrate for the first time that Skp2 is an important factor in VSMC proliferation and its inhibition by cyclic nucleotides...
  29. ncbi Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis
    Jason L Johnson
    Bristol Heart Institute, University of Bristol, Bristol, England
    Circulation 113:2435-44. 2006
    ..We hypothesized that overexpression of tissue inhibitor of metalloproteinase (TIMP)-1 or TIMP-2 would attenuate atherosclerotic plaque development and instability in high fat-fed apolipoprotein E-knockout (apoE(-/-)) mice...
  30. ncbi Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts
    Gavin J Murphy
    Bristol Heart Institute, University of Bristol, Bristol, BS2 8HW, UK
    Cardiovasc Res 73:607-17. 2007
    ..We investigated short- and long-term effects of anti-proliferative pharmacological agents on experimental pig vein-grafts with similar dimensions and kinetics to human coronary grafts...
  31. ncbi On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents
    Jamie Y Jeremy
    Bristol Heart Institute, University of Bristol, UK
    Biomaterials 28:895-908. 2007
    ....
  32. ncbi Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo
    Alexander J Chase
    University of Bristol, Bristol Heart Institute, Bristol, UK
    Arterioscler Thromb Vasc Biol 22:765-71. 2002
    ..Because the inhibition of NF-kappaB reduces proteolytic activity, it appears to be an attractive pharmacological target in unstable atheromas...
  33. ncbi Genomics of foam cells and nonfoamy macrophages from rabbits identifies arginase-I as a differential regulator of nitric oxide production
    Anita C Thomas
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, United Kingdom
    Arterioscler Thromb Vasc Biol 27:571-7. 2007
    ..We sought to identify genes differentially regulated in foam cells, since these are likely to include new targets for intervention...
  34. ncbi Activation of protein kinase Czeta is essential for cytokine-induced metalloproteinase-1, -3, and -9 secretion from rabbit smooth muscle cells and inhibits proliferation
    Shaista Hussain
    Bristol Heart Institute and University Research Centre for Neuroendocrinology, Royal Infirmary, University of Bristol, Bristol BS2 8HW, UK
    J Biol Chem 277:27345-52. 2002
    ..Selective inhibition of PKCzeta is therefore a possible strategy to inhibit MMP production in inflammatory diseases such as atherosclerosis...
  35. ncbi [Stent-based local delivery of therapeutic adenovirus effectively reduces neointimal proliferation in porcine coronaries]
    Yin Xiong Wu
    Guangxi Municipal Hospital, Nanning 530021, China
    Di Yi Jun Yi Da Xue Xue Bao 23:1263-5. 2003
    ..To find an effective means for delivering therapeutic genes of Tissue inhibitor of metalloproteinase-3 (TIMP-3) to the target sites of the dilated coronary artery for the purpose of preventing restenosis of the injured artery...
  36. ncbi Vitronectin is implicated as the matrix takes control of neointima formation
    Andrew C Newby
    Cardiovasc Res 53:779-81. 2002
  37. ncbi Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway
    Mark Bond
    Bristol Heart Institute, Level 7, Bristol Royal Infirmary, University of Bristol, Bristol BS2 8HW, United Kingdom
    J Biol Chem 277:13787-95. 2002
    ..Taken together, these results indicate that TIMP-3 overexpression induces a type II apoptotic pathway initiated via a Fas-associated death domain-dependent mechanism...
  38. ncbi Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells
    Saima Muzaffar
    Bristol Heart Institute, University of Bristol, Bristol, UK
    J Vasc Res 45:521-8. 2008
    ....
  39. ncbi Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages
    Jason L Johnson
    Bristol Heart Institute, University of Bristol, England
    Arterioscler Thromb Vasc Biol 28:1647-53. 2008
    ..An excess of metalloproteinases (MMPs) over tissue inhibitors of metalloproteinases (TIMPs) may favor atherosclerotic plaque rupture. We compared TIMP levels in nonfoamy and foam-cell macrophages (FCM) generated in vivo...
  40. ncbi Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells
    Mohammed A Majid
    Institute of Ophthalmology, University of Bristol, Bristol Eye Hospital, Lower Maudlin Street Bristol BS1 2LX, UK
    Br J Ophthalmol 86:97-101. 2002
    ..The mechanism of cell death was apoptosis. CONCLUSION: The previously unreported finding of TIMP-3 induced apoptosis of RPE cells may account for some of the early features seen in SFD and ARMD...
  41. ncbi Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: role of the cyclin dependent kinases and their inhibitors
    Tanya D Izzard
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK
    Cardiovasc Res 53:242-52. 2002
    ..CONCLUSIONS: Cell cycle entry is prevented in aortic tissue, and this is associated with an inability to downregulate p16 and p27 CKIs, and therefore to activate cyclin D1 and cyclin E associated kinase activities...
  42. ncbi From tadpole tails to transgenic mice: metalloproteinases have brought about a metamorphosis in our understanding of cardiovascular disease
    Andrew C Newby
    Cardiovasc Res 69:559-61. 2006
  43. ncbi Regulation of vascular smooth muscle cell proliferation, migration and death by heparan sulfate 6-O-endosulfatase1
    Graciela B Sala-Newby
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom
    FEBS Lett 579:6493-8. 2005
    ..Our results imply that only normal levels of 6-O-sulfation maintained by sulf1 are optimal for several functions of VSMC...
  44. ncbi R-cadherin:beta-catenin complex and its association with vascular smooth muscle cell proliferation
    Sadie C Slater
    Bristol Heart Institute, Department of Cardiac, Anesthetic, and Radiological Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, UK
    Arterioscler Thromb Vasc Biol 24:1204-10. 2004
    ..Outside-in signaling from the cadherin:beta-catenin complex can increase transcription of the cell-cycle gene cyclin D1; however, its role in VSMC proliferation has only recently been considered...
  45. ncbi Gene therapy for all aspects of vein-graft disease
    Stephen J White
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK
    J Card Surg 17:549-55. 2002
    ..This might be enough by itself to decrease later atherosclerosis. Alternatively, direct targeting with nitric oxide synthase, decoy adhesion molecules, or interleukin-10 might be possible...
  46. ncbi Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling
    Alex J Chase
    Bristol Heart Institute, University of Bristol, Bristol, UK
    J Vasc Res 40:329-43. 2003
    ..Studying the detailed mechanisms involved may suggest possibilities for intervening selectively against pathological MMP induction...
  47. ncbi Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries
    Thomas W Johnson
    Bristol Heart Institute, University of Bristol, Bristol, UK
    Arterioscler Thromb Vasc Biol 25:754-9. 2005
    ..005). CONCLUSIONS: Our results demonstrate for the first time to our knowledge the feasibility of adenovirus-coated stent technology and highlight the potential of TIMP-3 to produce significant inhibition of in-stent neointima formation...
  48. ncbi Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation
    Elizabeth B Uglow
    Bristol Heart Institute, Level 7, Bristol Royal Infirmary, Bristol, BS2 8HW, UK
    Circ Res 92:1314-21. 2003
    ..Furthermore, disruption of N-cadherin cell-cell contacts mediated in part by metalloproteinase activity occurs during VSMC proliferation, releasing beta-catenin and possibly inducing beta-catenin-mediated intracellular signaling...
  49. ncbi Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation
    Mark Bond
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK
    Cardiovasc Res 69:198-206. 2006
    ..Here we investigate the mechanisms regulating p21Cip1 levels in VSMCs and its role in controlling VSMC proliferation...
  50. ncbi Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries
    Jason L Johnson
    Bristol Heart Institute, University of Bristol, Bristol BS2 8HW, United Kingdom
    Proc Natl Acad Sci U S A 102:15575-80. 2005
    ..These data demonstrate that MMPs are directly involved in atherosclerotic plaque destabilization and clearly show that members of the MMP family have widely differing effects on atherogenesis...
  51. ncbi An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs
    Gianni D Angelini
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United Kingdom
    J Thorac Cardiovasc Surg 124:950-6. 2002
    ....
  52. ncbi Focal adhesion kinase (FAK)-dependent regulation of S-phase kinase-associated protein-2 (Skp-2) stability. A novel mechanism regulating smooth muscle cell proliferation
    Mark Bond
    Bristol Heart Institute, University of Bristol, Bristol BS2 8HW, United Kingdom
    J Biol Chem 279:37304-10. 2004
    ..Taken together, these data demonstrate that the vascular ECM controls SMC proliferation via FAK-dependent regulation of Skp-2 protein stability...
  53. ncbi Metabolic and functional consequences of cytosolic 5'-nucleotidase-IA overexpression in neonatal rat cardiomyocytes
    Graciela B Sala-Newby
    Bristol Heart Institute, Bristol Royal Infirmary, University of Bristol, Bristol BS2 8HW, UK
    Am J Physiol Heart Circ Physiol 285:H991-8. 2003
    ..90 +/- 4 beats/min). Our results demonstrate that overexpressed cN-IA can be sufficiently active in cardiomyocytes to generate physiologically effective concentrations of adenosine at its receptors...
  54. ncbi Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy
    Kate L Dishart
    Division of Cardiovascular and Medical Sciences, University of Glasgow, Church Street, G11 6NT, Glasgow, UK
    J Mol Cell Cardiol 35:739-48. 2003
    ..We have demonstrated for the first time the potential for third-generation lentiviral vectors, but not alternate AAV serotypes, as efficient vascular gene delivery vectors...
  55. ncbi The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling
    Marjo M P C Donners
    Department of Pathology, Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, The Netherlands
    Blood 111:4596-604. 2008
    ..This identifies the CD40-TRAF6 axis as a potential therapeutic target in vascular disease...
  56. ncbi Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages
    Ernesto Oviedo-Orta
    Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK
    Immunology 124:42-50. 2008
    ..These mechanisms could promote matrix turnover in inflammatory states and, for example, promote atherosclerotic plaque rupture...
  57. ncbi A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study
    Gavin J Murphy
    Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United Kingdom
    J Thorac Cardiovasc Surg 134:504-5. 2007
  58. ncbi CD4+ T lymphocyte subsets express connexin 43 and establish gap junction channel communication with macrophages in vitro
    Alexandra Bermudez Fajardo
    School of Biomedical and Molecular Sciences, University of Surrey, Guildford GU2 7XH, UK
    J Leukoc Biol 82:608-12. 2007
    ..Therefore, a further mechanism featuring gap junction-mediated communication may be implicated in immune regulation...
  59. ncbi Flow antagonizes TNF-alpha signaling in endothelial cells by inhibiting caspase-dependent PKC zeta processing
    Gwenaele Garin
    University of Rochester, Cardiovascular Research Institute, Box 679, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Circ Res 101:97-105. 2007
    ..These results define a novel role for PKCzeta as a shared signaling mediator for flow and TNF-alpha, and important for flow-mediated inhibition of proinflammatory and apoptotic events in ECs...
  60. ncbi Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3
    Mohammed A Majid
    Bristol Eye Hospital, Lower Maudlin Street, Bristol BS1 2LX, UK
    Br J Ophthalmol 91:1073-6. 2007
    ..Sorsby's fundus dystrophy (SFD) is a degenerative retinopathy characterised by accumulation of mutant TIMP-3 protein in Bruch's membrane...
  61. ncbi Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells
    Mohammed A Majid
    Institute of Ophthalmology, University of Bristol, Bristol Eye Hospital, Lower Maudlin Street, Bristol BS1 2LX, UK
    FEBS Lett 529:281-5. 2002
    ..Adenovirus-mediated overexpression of the Gly-167 mutant also caused RPE apoptosis dose-dependently. Apoptosis of RPE cells might therefore contribute to the pathology of SFD...
  62. ncbi Studying mechanisms underlying shedding of endothelial membrane proteins could help patients at risk for myocardial infarction
    Andrew C Newby
    Cardiovasc Res 67:4-5. 2005
  63. ncbi Both ICAM-1- and VCAM-1-integrin interactions are important in mediating monocyte adhesion to human saphenous vein
    Martin F Crook
    Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, UK
    J Vasc Res 39:221-9. 2002
    ..These experiments imply that either integrin might be targeted to reduce monocyte infiltration into HSV grafts...
  64. ncbi Peptide-retargeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer
    Mikko P Turunen
    A. I. Virtanen Institute, University of Kuopio, Kuopio, Finland
    Mol Ther 6:306-12. 2002
    ....